Skip to Content
Merck
  • Prevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative staphylococci from very preterm neonates in NICU: the creeping threat?

Prevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative staphylococci from very preterm neonates in NICU: the creeping threat?

The Journal of hospital infection (2013-02-19)
M Lepainteur, G Royer, A S Bourrel, O Romain, C Duport, F Doucet-Populaire, J-W Decousser
ABSTRACT

In neonatal intensive care units, topical agents represent an increasing part of the infection control armamentarium. Fifty-one coagulase-negative staphylococci (CNS) isolated from catheter-associated bloodstream infections in very preterm neonates were investigated in this study: 41.2% exhibited decreased susceptibility to at least one antiseptic (chlorhexidine 12%, benzalkonium 24%, acriflavine 33%) and 61% were resistant to mupirocin. QacA/B, mupA and both genes were detected by polymerase chain reaction in 59%, 63% and 49% of CNS, respectively. Seventy-six percent of Staphylococcus epidermidis (5/5 pulsed-field-gel electrophoresis subgroups) and 11% of Staphylococcus capitis (1/3 subgroups) were multi-resistant. Skin antisepsis using low-concentration aqueous formulations and off-label mupirocin indications should benefit from a stewardship programme.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Mupirocin, ≥92% (HPLC), powder
Sigma-Aldrich
Lithium mupirocin, ≥95.0% (HPLC)
Millipore
Lithium mupirocin Supplement, suitable for microbiology,

Selectively inhibits the growth of lactic acid bacteria